Heart Center Research, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts

Phase 4

Recruiting

Conditions: Heart Failure, Congestive

Interventions: Drug: sacubitril/valsartan
Drug: Furosemide
Drug: Hydralazine
Drug: Torsemide
Drug: Bumetanide
Drug: Isosorbide Dinitrate

First Posted Date: 2024-01-23

Last Posted Date: 2024-01-29

Lead Sponsor: Heart Center Research, LLC

Target Recruit Count: 80

Registration Number: NCT06218199

Locations: 🇺🇸
Heart Center Research, LLC, Huntsville, Alabama, United States

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy